Metraipolis › archive › dc_df5b281f596f

Targeted RNA Degradation as a Promising Therapeutic Strategy — Europe PMC PMID:41226803

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41226803
DOI: 10.3390/ijms262110767
License (as archived): solo-consultazione
Archived: 2026-11-08T19:10:40.827Z
SHA-256 of the archived text: eaaaa671194f8defd8c6fda007ffef93ee0748e7179920b1ce4c0a9c1d291927
Stable URL of this page: https://metraipolis.com/documento/dc_df5b281f596f

How to cite

Targeted RNA Degradation as a Promising Therapeutic Strategy — Europe PMC PMID:41226803 — Europe PMC (en), https://europepmc.org/article/MED/41226803 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df5b281f596f (Metraipolis archive dc_df5b281f596f, sha256 eaaaa671194f8defd8c6fda007ffef93ee0748e7179920b1ce4c0a9c1d291927)

BibTeX

@misc{dcdf5b281f596f,
  title = {Targeted RNA Degradation as a Promising Therapeutic Strategy — Europe PMC PMID:41226803},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41226803},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df5b281f596f; sha256 eaaaa671194f8defd8c6fda007ffef93ee0748e7179920b1ce4c0a9c1d291927},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226803. Agents can read the archived copy with the MCP tool read_document.